Rafael Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RFL research report →
Price Chart
About the company
Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate.
- CEO
- Howard S. Jonas
- IPO
- 2018
- Employees
- 17
- HQ
- Newark, NJ, US
Get TickerSpark's AI analysis on RFL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $47.27M
- P/E
- -1.57
- PEG
- -0.02
- P/S
- 53.71
- P/B
- 0.71
- EV/EBITDA
- -0.89
- Div Yield
- 0.00%
- Gross Margin
- 71.85%
- Op Margin
- -3821.17%
- Net Margin
- -3390.73%
- ROE
- -38.73%
- ROIC
- -45.95%
Latest fiscal year · YoY change
- Revenue
- $874.00K-4.7%
- Gross Profit
- $628.00K+26.9%
- Op Income
- $-33,409,000
- Net Income
- $-29,635,000+2.9%
- EPS
- $-0.58+44.2%
- OCF Growth
- +175.7%
- FCF Growth
- +175.7%
- 52W High
- $3.96
- 52W Low
- $0.78
- 50D MA
- $1.45
- 200D MA
- $1.67
- Beta
- 0.35
- RSI (14)
- 31
- Avg Volume
- 140.61K
No earnings-call transcripts are available for RFL yet.
- Free Float
- 62.2%
- Shares Outstanding
- 51.40M
- Float Shares
- 31.95M
of shares held by institutions
44 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 1.49M | ▲ 98.55K |
| Vanguard Capital Management LLC | 1.35M | ▼ 19.50K |
| Geode Capital Management, LLC | 401.68K | ▼ 28.20K |
| Blackrock, Inc. | 386.69K | ▼ 3.38K |
| Dimensional Fund Advisors LP | 288.78K | ▲ 9.87K |
| Vanguard Fiduciary Trust Co | 188.55K | ▼ 17.97K |
| Founders Fund V Management, LLC | 169.45K | 0 |
| Jane Street Group, LLC | 163.94K | ▲ 51.22K |
| State Street Corp | 157.27K | 0 |
| Ieq Capital, LLC | 144.68K | ▼ 20.28K |
| Susquehanna International Group, Llp | 130.19K | ▲ 59.51K |
| Stifel Financial Corp | 122.13K | ▲ 122.13K |
Held by 37 ETFs
Biggest fund positions in RFL by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 25, 26 | Polinsky David | other | 4,245 |
| Sep 21, 26 | Polinsky David | other | 2,027 |
| Jul 29, 26 | JONAS HOWARD S | other | 54,945 |
| Jun 21, 26 | Polinsky David | other | 2,386 |
| Jun 13, 26 | JONAS HOWARD S | other | 142,857 |
| Jun 13, 26 | JONAS HOWARD S | other | 8,786 |
| Mar 21, 26 | Polinsky David | other | 2,318 |
| Mar 13, 26 | JONAS HOWARD S | other | 9,826 |
| Jan 28, 26 | Sieger Markus | other | 29,528 |
| Jan 28, 26 | WEISS MICHAEL J | other | 39,370 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RFL coverage
Recent articles, reports, and earnings notes.
No research on RFL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RFL report →INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
prnewswire.com · Nov 12
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
globenewswire.com · Nov 10
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
prnewswire.com · Nov 5
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
globenewswire.com · Nov 3
Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
globenewswire.com · Nov 3
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL
prnewswire.com · Oct 29
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update
globenewswire.com · Oct 29
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
globenewswire.com · Oct 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.